Deratin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Deratin

What is Deratin? (Foundational Overview)

Property Description
Active ingredient Chlorhexidine Gluconate
Form Solution, Gel, Oral rinse, Spray
Pharmacological class Antiseptic and Disinfectant
General purpose Broad-spectrum antimicrobial control
Origin Synthetic (Cationic Bis-biguanide)

What Type of Medicine is Deratin?

Deratin is a topical or local-application medicine defined by its active component, Chlorhexidine Gluconate, which is used extensively for microbial control and hygiene. It belongs to the pharmacological class of antiseptics and disinfectants, a classification that is recognized for its essential role in preventing localized infections.

The active component, Chlorhexidine Gluconate, is a synthetic cationic bis-biguanide. Deratin is often manufactured as an over-the-counter (OTC) product in forms intended for general population use, typically focusing on oral hygiene or routine skin cleansing applications. The synthetic origin ensures consistent chemical potency, and the medicine is a monocomponent product, relying entirely on this single active substance for its action.

Forms, Composition, and General Purpose

Deratin is manufactured as a topical or local-application medicine and is available in various dosage forms, including aqueous solutions (often used as oral rinses), gels, and sprays. Its composition involves the active Chlorhexidine Gluconate combined with an appropriate base or vehicle to ensure delivery to the target area.

The general purpose of these preparations is to achieve broad-spectrum antimicrobial control on the applied surfaces. For example, a common use scenario involves using the oral rinse form to maintain hygiene following dental work. Its efficacy as an antimicrobial agent supports its function in maintaining a clean environment conducive to natural recovery processes.

How Does Chlorhexidine Provide Antimicrobial Control?

Chlorhexidine Gluconate achieves microbial control primarily through a direct bactericidal effect. The compound targets and disrupts the outer membranes of microbial cells, leading to their inactivation. This mechanism allows the agent to rapidly reduce pathogen load upon contact. A key characteristic of Chlorhexidine is its property of substantivity, where the agent binds to the tissue surface. This binding allows the Chlorhexidine Gluconate to remain active for a period after application, sustaining a state of reduced microbial presence locally.

What side effects are possible with Deratin?

Possible Side Effects and Safety Information

Deratin (Chlorhexidine Gluconate) has an officially documented safety profile characterized primarily by localized adverse reactions. These effects are categorized in regulatory documents based on frequency and the body system affected.


Common Adverse Reactions

The most frequently reported side effects are generally associated with the topical application site. In oral rinse forms, this includes discoloration or staining of the teeth, the tongue, and dental restorations, which is often professionally removable, and an increase in the rate of calculus (tartar) formation . Alteration in taste perception and a transient burning sensation of the tongue are also classified as common; these effects typically lessen with continued use.

Serious and Systemic Safety Concerns

A rare but officially recognized risk is the development of serious generalized allergic reactions, including anaphylaxis. These immune system reactions can be immediate and severe. While systemic absorption is low, the risk of serious side effects is formally noted, especially when the product is applied over large or damaged areas of skin, such as extensive burns.


Safety Restrictions and Special Populations

Official labeling mandates strict constraints on application: Deratin must not come into direct contact with the eyes, the middle ear (via a perforated eardrum), or nervous tissue due to the potential for serious or permanent injury. A specific safety consideration is documented for neonates, particularly preterm infants, who have an increased risk of developing chemical burns following topical application.

Overdose and Emergency Response

The official regulatory profile for Deratin (Chlorhexidine Gluconate) identifies two primary scenarios requiring emergency action: severe allergic hypersensitivity and accidental oral ingestion.

A serious allergic reaction can manifest with rapid-onset symptoms such as wheezing, difficulty breathing, swelling of the face, or a severe rash. These manifestations are documented to potentially progress to shock and represent a life-threatening outcome in rare cases. If any symptom of a serious allergic reaction occurs, the official guidance is to stop use and seek medical attention immediately.

Accidental oral ingestion of large volumes of the preparation may lead to gastric distress, including nausea. For products containing ethanol, signs of alcohol intoxication, such as slurred speech or a staggering walk, may also be present. Regulatory authorities specify that if a volume exceeding certain thresholds (e.g., more than four ounces for a small child) is swallowed, the user must contact a Poison Control Center.

The official documentation defines the management of overdose as primarily consisting of symptomatic and supportive measures. No specific antidote for Chlorhexidine overdose is listed in the regulatory prescribing information. The need for hospitalization is a documented outcome in cases of severe hypersensitivity or systemic intoxication.

Therapeutic Uses of Deratin

What Deratin Treats: Main Uses and Benefits

Deratin, which contains Chlorhexidine Gluconate, is applied locally and may be part of symptomatic management in situations involving certain distressing symptoms. Its uses are centered on addressing conditions involving inflammatory or irritative processes driven by microbial presence and reducing the risk of localized infection. This medication is relevant for managing symptoms linked to gum health.

Control of Gum Inflammation and Microbial Plaque

This medicine is commonly used to help manage the symptoms related to inflammatory or irritative states of the gums, such as redness, swelling, and bleeding, that are often linked to dental plaque. It contributes to easing the overall symptom load associated with conditions characterized by periods of heightened symptoms, like gingivitis. It may be part of symptomatic management during chronic plaque management.

Support for High-Risk Oral and Topical Scenarios

Deratin is commonly used when short-term symptomatic assistance is needed in specific, high-risk scenarios. This includes post-operative care following dental procedures to maintain hygiene and supports general well-being during the post-procedural phase. In its topical forms, it is applied in addressing localized risk, which assists with maintaining functional stability by reducing the risk of developing infection in minor skin breaches or at the insertion sites of medical devices. This makes it relevant across domains where additional symptomatic support is needed.


Quick Fact: Relief for Inflammatory Symptoms Deratin supports the reduction of gum swelling and bleeding in patients with gingivitis by easing distress associated with inflammatory or irritative states.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Deratin's eligibility profile is strictly defined by regulatory documents, outlining populations that are permitted to use the medicine and those who are officially excluded or restricted.

Contraindicated Populations

Use of this medicine is absolutely contraindicated for any individual with a documented hypersensitivity or allergy to the active ingredient, Chlorhexidine Gluconate, or to any other ingredient present in the specific formulation. This prohibition represents the primary regulatory exclusion.


Age-Related Eligibility

The established use for Deratin is primarily defined for adults (age 18 and older). Safety and effectiveness have not been established in pediatric patients under the age of 18, according to official regulatory data. No specific age-based restrictions are documented for older adults.


Conditional Use and Restrictions

Eligibility is restricted for certain populations. For pregnant women, the medicine is classified as Pregnancy Category B, and its use is conditional, recommended only if clearly needed. Nursing mothers must use the medicine with caution, as it is not known if the drug is excreted in human milk. Furthermore, use may be restricted for patients with specific anterior facial restorations if permanent discoloration resulting from the medicine is an aesthetic concern.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information highlights several important interactions that define the safe use of this product.


Medicinal Product and Category Interactions

  • Other Oral Antiseptics: Concomitant use with other medications for local application to the mouth or throat should generally be avoided unless specifically directed by a healthcare professional.
  • Cholinesterase Inhibitor Drugs: Co-administration with cholinesterase inhibitors, often used for conditions like Alzheimer's disease, is advised against.
  • Sulfonamides: Use with sulfonamide-based antibiotics is a reported interaction and should be avoided.

Functional and Diagnostic Interferences

  • Toothpaste Components: The effectiveness of Chlorhexidine is known to be reduced by anionic compounds and suspending agents found in common toothpastes. To mitigate this effect, the mouth should be thoroughly rinsed with water after brushing before using this product.
  • Diagnostic Test Interference: This product may alter the results of certain diagnostic procedures. Specifically, it should not be taken for at least three days prior to the pancreatic function test using bentiromide, as it can interfere with the test's results.

These constraints define the necessary precautions for co-prescribing and for preparing for certain analytical procedures, emphasizing avoidance or necessary separation from other specific oral treatments.

Mechanism of Action

How Deratin Works

Deratin (Chlorhexidine Gluconate) functions as a non-systemic antiseptic through two core mechanistic domains that establish its localized and prolonged effect.


Direct Cationic Membrane Disruption

This domain covers the primary molecular interaction: the cationic drug rapidly binds via electrostatic adsorption to the negatively charged microbial cell membrane, causing immediate structural destabilization. This physical compromise results in the leakage of vital intracellular components, leading to a prompt microbicidal effect and results in a rapid reduction in local microbial load.


Tissue Binding for Sustained Local Activity

This secondary mechanism is known as substantivity. The drug molecule binds tightly to the macromolecules on host tissues (like the oral mucosa), creating a local reservoir. The slow, continuous release from this binding site prolongs the effective concentration of the agent. The continuous release maintains a prolonged local concentration of the agent, resulting in sustained local microbial load modulation after initial application.

Dosage and Administration Information

The usage of Deratin (Chlorhexidine Gluconate) is defined by its dosage form and administration route. The medicine is classified for local application, with specific instructions governing its use as an oral rinse, a topical solution, and a subgingival chip.

Administration Scope

The standard regimen for the 0.12% oral rinse is 15 mL of the solution, used twice daily, generally in the morning and evening. The rinse must be used undiluted, swished for 30 seconds, and then expelled. This procedure must occur after cleaning the teeth and rinsing away all toothpaste residue. A procedural constraint requires patients to refrain from eating, drinking, or rinsing with water for 30 minutes following use to ensure maximum exposure time.

For the topical forms, such as 2% or 4% solutions, the application requires use of the minimum necessary amount. In surgical settings, the solution must be allowed to air dry completely before covering or using heat sources. For the subgingival 2.5 mg chip, applications are limited to a maximum frequency of once every 3 months.

Population-Specific Rules

Administration rules for specific populations are established for this medication. The oral rinse is not established for use in patients under 18 years of age. For topical solutions, use is generally not recommended in children younger than 2 months of age.

Course Duration

The overall use protocol is cyclic and requires monitoring. Oral rinse therapy typically requires patient re-evaluation at intervals no longer than six months to assess the continued need for treatment. This establishes a required duration monitoring protocol.

Recent Clinical Evidence

Research evidence / Overview of studies for Deratin (Chlorhexidine Gluconate)


Evidence for Managing Gum Inflammation Symptoms

Research has examined studies involving Deratin preparations that focused on managing gum inflammation symptoms, such as gingivitis. The evidence primarily comes from short-term and intermediate-term Randomized Controlled Trials (RCTs), supported by systematic reviews. Researchers primarily monitored outcomes by using standardized measurement systems to track changes in dental plaque indices and the specific symptoms of gum inflammation, such as redness and bleeding.

Studies conducted generally report measurements observed in the studies that are related to the dental plaque indices when Deratin was observed in conjunction with regular brushing. However, long-term effects are not fully established regarding the maintenance of these measured changes. Evidence quality varies across studies, and data exploring outcomes for populations with more moderate-to-severe inflammation are still limited.


Evidence for Support After Dental Procedures

Deratin was evaluated in studies focusing on short-term support following various dental surgeries, including extractions and implant procedures. The research base involves RCTs and Systematic Reviews focused on the immediate recovery phase. In these settings, research examined outcomes such as the rate of post-operative complications and the local control of bacteria.

Studies focusing on these research scenarios report how symptoms evolved in the observed populations in the days and weeks immediately following the procedure. Data suggest patterns related to the observed incidence of specific post-extraction complications, such as alveolar osteitis. Follow-up durations were limited in many of these studies, concentrating on the first few weeks after the procedure.


Research on Topical Antimicrobial Control for Skin

The use of Deratin preparations on the skin surface was evaluated in numerous comparative efficacy studies and controlled trials regarding antiseptic standards. These studies monitored outcomes by measuring the immediate and persistent change in the population of bacteria on the skin. Research also explored the potential for the product to cause skin irritation and tracked the frequency of localized infections related to certain medical devices.

Research describes findings related to microbial counts on the applied area that were monitored for persistence. Findings describe patterns observed in the studies related to outcomes monitoring the frequency of localized infections in certain high-risk clinical settings. However, the evidence was observed in some studies where the active ingredient was combined with other substances, such as alcohol, which makes it hard to isolate the effect of Deratin alone.

Frequently Asked Questions (FAQ)

Common questions about Deratin (FAQ)

Q: Is Deratin considered a long-term or short-term medicine?

A: According to official product labeling, clinical effectiveness for the oral rinse was established over a six-month period. For continued use beyond that duration, official protocols suggest that patient re-evaluation may be necessary to determine the ongoing need for the medicine. Some formulations are generally advised for short-term use to limit the risk of common side effects like dental staining.

Q: How quickly can I expect to see an effect after starting Deratin?

A: Official information states that the medicine provides antimicrobial activity and that the full clinical benefits may take up to six weeks to become apparent with regular use.

Q: Does taking Deratin require any special dietary changes?

A: Official product information suggests waiting at least 30 minutes after use before rinsing your mouth with water, eating, or drinking. This timing helps ensure the medicine remains active on the applied surface.

Q: Can Deratin affect my ability to drive or operate machinery?

A: Official product information states that this medicine has no or negligible influence on the ability to drive or operate machines.

Q: What happens if I forget to take Deratin one day?

A: Regulatory guidance describes skipping the forgotten dose if the next dose is approaching. Official instructions caution against taking a double dose to compensate for a missed one.

Q: Are there any specific vitamins or supplements that are known to interfere with Deratin?

A: Regulatory documentation does not list specific interactions with common vitamins or supplements. However, official patient information suggests discussing all prescription and non-prescription drugs, vitamins, minerals, and supplements being used with a healthcare professional.

Q: Is Deratin safe for use by older adults (e.g., people over 65)?

A: Official regulatory information states that there is no specific information available on the relationship of age to the effects of this medicine in geriatric patients (older adults).

Q: Can Deratin be used safely by women who are planning pregnancy?

A: Official guidelines recommend that women who are pregnant or planning to become pregnant discuss this medicine with their healthcare professional.

Q: Why are people often told to avoid alcohol completely when taking Deratin?

A: The oral rinse formulations contain alcohol, and official warnings highlight that accidental ingestion of large amounts by small children may result in signs of alcohol intoxication. Furthermore, alcohol-containing topical solutions are flammable, and official warnings state that they should be kept away from heat or ignition sources.

Q: What is the official classification of Deratin (e.g., controlled substance)?

A: According to regulatory classifications in the United States, the oral rinse form of this medicine is classified as a Human Prescription Drug. It is not a DEA-scheduled controlled substance.

Q: How long does Deratin stay in my system after I stop taking it?

A: Studies indicate that the medicine is very poorly absorbed from the gastrointestinal tract. Due to the lack of significant systemic exposure, regulatory documents do not specify a bloodstream clearance timeline.

Q: Is the 'half-life' of Deratin relevant for how often it is usually taken?

A: Yes. The medicine's mechanism involves a property called substantivity, where the drug binds to local tissues. This binding action provides sustained antimicrobial activity that is maintained between doses, a characteristic that helps maintain the specified dosing interval.

Q: Are there any ongoing clinical trials for new uses of Deratin?

A: Information regarding ongoing clinical trials for this drug, including those for potential new uses, is maintained by official sources. This information is typically linked directly from the official regulatory label page, such as the DailyMed resource.

Q: Is it normal to feel a little dizzy when first starting Deratin?

A: Dizziness is not listed as a common side effect of this medicine. However, official warnings cite severe dizziness as a potential symptom of a rare but serious generalized allergic reaction (anaphylaxis).

Q: Can Deratin change the results of standard lab tests?

A: Yes. Regulatory documents state that this product may interfere with the results of certain diagnostic procedures. Specifically, the medicine can alter the results of the pancreatic function test using bentiromide. Official information suggests caution regarding its use in the days prior to this test.

Q: What is the recommended protocol if I experience a mild, common side effect?

A: If an individual experiences a known common side effect, or if any side effect becomes troublesome enough to interfere with daily activities, official guidance suggests consulting a healthcare professional.

Q: Does Deratin affect blood pressure or heart rate?

A: Changes in blood pressure, particularly hypotension (low blood pressure), have been reported in official warnings. This effect is cited in association with rare, severe generalized allergic reactions (anaphylaxis), which are immune system responses.

Q: Is there a generic version of Deratin available yet?

A: Yes. The active ingredient, Chlorhexidine Gluconate, is the generic name for this drug. The medicine is available under several different generic names and branded product names across various formulations.

Q: Can Deratin be split or crushed if I have trouble swallowing pills?

A: This medicine is produced as a liquid oral rinse, a topical solution, or a subgingival chip. It is not available in a tablet or capsule form intended to be swallowed, so there are no instructions for splitting or crushing.

Q: Is Deratin known to cause sun sensitivity or skin issues?

A: Official regulatory documentation lists several localized skin issues as potential adverse effects, including dermatitis, rash, and skin irritation. However, the risk of sun sensitivity, known as photosensitivity, is not explicitly listed in the official warnings.

Q: Why are there different strengths of Deratin available?

A: Different strengths of the active ingredient are available because they are approved for different administration routes and medical purposes. For instance, the lower 0.12% strength is approved for oral use, while the higher 2% or 4% solutions are typically used for topical skin cleansing and antisepsis.

Q: Does Deratin need to be taken at a specific time of day?

A: Yes. Official instructions for the oral rinse typically direct the use of the medicine twice daily, generally specified as after breakfast in the morning and before bedtime in the evening.

Q: What does 'contraindicated' mean in the context of who can't use Deratin?

A: The regulatory term contraindicated means that the medicine should not be used because the risk to the patient outweighs the potential benefits. The primary contraindication for this medicine is a known allergy or hypersensitivity to the active ingredient or to any other ingredient in the specific formulation.

Q: What is the difference between a 'serious' side effect and a 'common' side effect for Deratin?

A: Regulatory documents classify side effects based on their frequency and severity. Common side effects are frequently reported, are usually localized (like staining or taste change), and tend to lessen with continued use. Serious side effects are rare, can be life-threatening (e.g., anaphylaxis), and often require emergency medical treatment.

Q: What are the known potential interactions between Deratin and herbal remedies?

A: No specific interactions with individual herbal remedies are listed in the regulatory documentation. However, official patient information suggests discussing all herbal products and supplements being used with a healthcare professional.

Q: Does the efficacy of Deratin decrease over time (tolerance)?

A: Regulatory patient materials advise that continuous or prolonged use of the oral rinse should be assessed, as using it for too long may mean it does not work as well over time and increases the risk of side effects like staining.

Q: What are the official sources for patient information about Deratin?

A: Official patient information is available in resources provided by governmental health authorities. Key sources include the US National Institutes of Health (DailyMed and MedlinePlus) and the specific Product Monograph from Health Canada or other national regulatory bodies.

Q: What should I know about the long-term safety profile of Deratin?

A: The safety profile for use over periods longer than six months has not been fully established through controlled studies. However, the most noted risk associated with long-term use is a greater frequency of common side effects, primarily the staining of teeth and dental work and increased tartar formation.

Q: Why are certain foods mentioned as potential interaction concerns with Deratin?

A: The instruction to wait 30 minutes before consuming food or drinks is intended to achieve two goals: to maximize the amount of time the active ingredient remains effective, and to minimize the temporary alteration in taste perception that some users may experience.

Q: Is Deratin available over the counter in any country?

A: Yes. Some topical skin antiseptic formulations containing Chlorhexidine Gluconate are typically available over-the-counter (OTC). However, the specific oral rinse and dental chip forms are generally classified as prescription-only medicines.

Q: How long does it usually take for common side effects of Deratin to go away?

A: Common side effects, such as a transient burning sensation on the tongue or an alteration of taste perception, are generally temporary. Regulatory information notes that these effects typically diminish with continued use of the medicine.

Q: What is the role of Deratin in the overall treatment plan for the condition it treats?

A: Regulatory documents indicate that the oral rinse is intended to be used as an adjunct (or addition) to daily mechanical hygiene. It is specifically used alongside, and is not a replacement for, regular tooth brushing and flossing to manage gingivitis symptoms.

Q: Are there any lifestyle factors that can influence how well Deratin works?

A: Official information notes that a thorough rinse beforehand may be necessary to minimize reduced effectiveness from toothpaste ingredients. Additionally, alcohol-containing topical solutions carry flammability warnings and should be kept away from fire, heat, or smoking.

Q: What are the requirements for monitoring (like blood tests) while taking Deratin?

A: Official treatment protocols require patient re-evaluation by a healthcare professional at regular intervals, typically no longer than six months. This monitoring is to assess the individual's progress and continued need for treatment, but routine systemic tests like blood work are generally not mentioned in the official documentation.

How should Deratin be stored and disposed of?

Storage Conditions

Official labeling requires Deratin (Chlorhexidine Gluconate) to be stored in its original container, tightly closed, at controlled room temperature (typically 20 C to 25 C).

It must be protected from light, excess heat, and moisture. It is mandatory to keep the product from freezing.

Alcohol-containing solutions are considered flammable and must be kept away from flames, heaters, or any ignition sources.

Handling and Disposal

The medicine must be kept out of the sight and reach of children in a secured location. For formulations with a limited period of use after opening, the product must be discarded after the specified in-use shelf-life (e.g., 28 days or 8 weeks).

Any unused or expired product must be disposed of in accordance with local regulations. Due to its toxicity to aquatic life, the product should not be poured into drains, sewers, or surface water.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Deratin found in:

A-Z Index: